Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

TBP

Tetra Bio Pharma (TBP)

Tetra Bio Pharma Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:TSXV:TBP
日付受信時刻ニュースソース見出しコード企業名
2021/05/1722 : 21PR Newswire (Canada)Tetra Bio-Pharma Announces Closing of Bought Deal OfferingTSXV:TBPTetra Bio Pharma Inc
2021/05/1106 : 29PR Newswire (Canada)Tetra Bio-Pharma Announces $10 Million "Bought Deal" Public OfferingTSXV:TBPTetra Bio Pharma Inc
2021/03/0223 : 22PR Newswire (Canada)Tetra Bio-Pharma Announces Closing of Bought Deal OfferingTSXV:TBPTetra Bio Pharma Inc
2021/02/2400 : 42PR Newswire (Canada)Tetra Bio-pharma Inc. Announces Upsizing of Previously Announced OfferingTSXV:TBPTetra Bio Pharma Inc
2021/02/2306 : 47PR Newswire (Canada)Tetra Bio-Pharma Inc. Announces $10 Million Bought Deal Offering of UnitsTSXV:TBPTetra Bio Pharma Inc
2021/02/0322 : 30PR Newswire (Canada)Tetra Bio-Pharma Inc. Announces Closing of Non-Brokered Private PlacementTSXV:TBPTetra Bio Pharma Inc
2020/11/0303 : 51PR Newswire (Canada)Tetra Bio-Pharma Inc. Acquires Common Shares of Mondias Natural Products Inc.TSXV:TBPTetra Bio Pharma Inc
2020/08/1721 : 38PR Newswire (Canada)Tetra Bio-Pharma and Mondias enter into final agreement for the purchase of Lumiera Health Innovation Inc.TSXV:TBPTetra Bio Pharma Inc
2020/07/3022 : 03PR Newswire (Canada)Tetra Bio-Pharma Announces Expected Effective Date of Listing on TSX of its Common Shares and WarrantsTSXV:TBPTetra Bio Pharma Inc
2020/07/2323 : 47PR Newswire (Canada)Tetra and Mondias jointly announce the acquisition of Tetra's subsidiary, Lumiera, by Mondias to create a new growth platformTSXV:TBPTetra Bio Pharma Inc
2020/05/2221 : 49PR Newswire (Canada)Tetra Bio-Pharma Announces Closing of Public OfferingTSXV:TBPTetra Bio Pharma Inc
2020/05/1600 : 09PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TBPTSXV:TBPTetra Bio Pharma Inc
2020/05/1600 : 07PR Newswire (Canada)IIROC Trading Resumption - TBPTSXV:TBPTetra Bio Pharma Inc
2020/05/1504 : 40PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TBPTSXV:TBPTetra Bio Pharma Inc
2020/05/1504 : 37PR Newswire (Canada)IIROC Trading Halt - TBPTSXV:TBPTetra Bio Pharma Inc
2020/04/0821 : 00PR Newswire (Canada)Tetra Offers Pro-Bono Regulatory and Quality Assurance Expertise to Companies Developing COVID-19 SolutionsTSXV:TBPTetra Bio Pharma Inc
2020/04/0821 : 00PR Newswire (Canada)Tetra offre de l'expertise réglementaire et en assurance qualité pro-bono à des compagnies qui développent des solutions ...TSXV:TBPTetra Bio Pharma Inc
2020/04/0207 : 12PR Newswire (Canada)Tetra Bio Pharma Announces Filing of Final Base Shelf Prospectus for up to $50 Million of SecuritiesTSXV:TBPTetra Bio Pharma Inc
2020/03/0600 : 30PR Newswire (Canada)Tetra Bio-Pharma Announces Exercise of Over-Allotment Option in Connection with Bought Deal FinancingTSXV:TBPTetra Bio Pharma Inc
2020/02/2107 : 11PR Newswire (Canada)Tetra Bio-Pharma Inc. Announces Listing of WarrantsTSXV:TBPTetra Bio Pharma Inc
2020/02/1323 : 58PR Newswire (Canada)Tetra Bio-Pharma Announces Closing of Bought Deal FinancingTSXV:TBPTetra Bio Pharma Inc
2020/02/0322 : 55PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TBPTSXV:TBPTetra Bio Pharma Inc
2020/02/0322 : 54PR Newswire (Canada)IIROC Trading Resumption - TBPTSXV:TBPTetra Bio Pharma Inc
2020/02/0322 : 08PR Newswire (Canada)Tetra Bio-Pharma Announces CAUMZ Program Update AND Expansion of Market Potential Following Type B Meeting with USA FDATSXV:TBPTetra Bio Pharma Inc
2020/02/0109 : 30PR Newswire (Canada)Tetra Bio-Pharma Receives Favorable Response Following Type B Meeting with USA FDA for CAUMZ™TSXV:TBPTetra Bio Pharma Inc
2020/01/3104 : 57PR Newswire (Canada)IIROC Trading Halt - TBPTSXV:TBPTetra Bio Pharma Inc
2020/01/2722 : 30PR Newswire (Canada)Tetra Bio-Pharma annonce l'augmentation de la taille du placement déjà annoncéTSXV:TBPTetra Bio Pharma Inc
2020/01/2722 : 30PR Newswire (Canada)Tetra Bio-Pharma Announces Upsizing of Previously Announced OfferingTSXV:TBPTetra Bio Pharma Inc
2020/01/2223 : 37PR Newswire (Canada)Tetra Bio-Pharma annonce un placement par voie de prise ferme de 10,0 millions de dollarsTSXV:TBPTetra Bio Pharma Inc
2020/01/2223 : 34PR Newswire (Canada)TETRA BIO-PHARMA - PRESS RELEASE CORRECTIONTSXV:TBPTetra Bio Pharma Inc
 Showing the most relevant articles for your search:TSXV:TBP